Studies from Caucasian populations, such as Australia and the United States, Germany, and Norway, report prevalence of BRAF V600 mutations in nodular melanomas at 22.37% [19], 37.7% [17], and 40.84% [20], respectively. The gene discussed is BRAF; the disease is nodular malignant melanoma.